Relevium Technologies Inc. (RLLVF)
Relevium Technologies Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Montreal, QC, CA. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $2.0M. On trailing twelve-month figures it carries a trailing P/E of -0.33, a net margin of -587.6%. Its beta of 2.51 implies it has historically moved more than the broad market.
Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand. It also offers dietary supplements under the LeefyLyfe label and skincare solutions marketed as the Push & Pull System. Additionally, Relevium has developed specialized lines such as Relevium Senior, aimed at older adults for inflammatory conditions affecting joints, heart, and brain, and Relevium Kids, providing nutraceuticals and oral nutritional supplements for children. Headquartered in Montreal, Canada, the company was formerly known as BIOflex Technologies Inc. until it rebranded to Relevium Technologies Inc. in December 2015.
Relevium Technologies Inc. is most often compared with the following Healthcare names: